Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 4/20 | 0.54 |
| ▸ | TOP1 | P11387 | 2/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | CYCS | P99999 | 2/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LDHA | P00338 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | STAT1 | P42224 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29501072 | 1.00 | TERT (0.54) | TERTTOP1CYP19A1ALDH1A1CYP1A2 | |
| SCHEMBL29021355 | 0.98 | TERT (0.52) | TERTTOP1CYP19A1ALDH1A1CYP1A2 | |
| SCHEMBL30385992 | 0.98 | TERT (0.52) | TERTTOP1CYP19A1ALDH1A1CYP1A2 | |
| SCHEMBL21808804 | 0.98 | TERT (0.52) | TERTTOP1CYP19A1ALDH1A1CYP1A2 | |
| SCHEMBL2423305 | 0.98 | TERT (0.52) | TERTTOP1CYP19A1ALDH1A1CYP1A2 | |
| SCHEMBL14445603 | 0.94 | TOP1 (0.62) | TERTTOP1CYP19A1ALDH1A1CYP1A2 | |
| SCHEMBL7240122 | 0.90 | TOP1 (0.70) | TERTTOP1CYP19A1CYCSENPP2 | |
| SCHEMBL7240682 | 0.90 | TERT (0.46) | TERTTOP1CYP19A1CYCSENPP2 | |
| SCHEMBL7246924 | 0.85 | TOP1 (0.53) | TERTTOP1CYP19A1ALDH1A1CYCS | |
| SCHEMBL17366430 | 0.84 | CYP19A1 (0.41) | TERTTOP1CYP19A1ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530614-B1 | Porphyrin coordination polymer nanospheres and nanorods | SANDIA CORPORATION (US) | 2013-09-10 | — | — | US | claimed |
| US-8324342-B1 | Porphyrin coordination polymer nanospheres and nanorods | SANDIA CORPORATION (US) | 2012-12-04 | — | — | US | claimed |
| US-7223474-B1 | Heteroporphyrin nanotubes and composites | SANDIA CORPORATION (US) | 2007-05-29 | — | — | US | claimed |
| US-7132163-B1 | Heteroporphyrin nanotubes and composites | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2006-11-07 | — | — | US | claimed |
| EP-0606453-B1 | PHOTOVOLTAIC CELL | ASULAB SA (CH) | 1997-06-04 | — | — | EP | claimed |
| US-5482570-A | Photovoltaic cell | ASULAB S.A. (CH) | 1996-01-09 | — | — | US | claimed |
| US-12546743-B2 | Electrochemical sensor and related methods | UNIVERSITY OF SOUTH FLORIDA (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-20230296554-A1 | ELECTROCHEMICAL SENSOR AND RELATED METHODS | UNIVERSITY OF SOUTH FLORIDA | 2023-09-21 | — | — | US | disclosed |
| US-11344574-B2 | Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same | DUKE UNIVERSITY (US) | 2022-05-31 | — | — | US | disclosed |
| EP-3183757-B1 | ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM | CLAP CO LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| US-20210361702-A1 | FLUORO SUBSTITUTED PORPHYRIN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | DUKE UNIVERSITY | 2021-11-25 | — | — | US | disclosed |
| EP-3687551-A1 | FLUORO SUBSTITUTED PORPHYRIN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | Duke University (US) | 2020-08-05 | — | — | EP | disclosed |
| EP-1045851-A1 | SUBSTITUTED PORPHYRINS | DUKE UNIVERSITY (US) | 2000-10-25 | — | — | EP | disclosed |
| WO-1999023097-A1 | SUBSTITUTED PORPHYRINS | DUKE UNIVERSITY (US) | 1999-05-14 | — | — | WO | disclosed |
| EP-0606453-B1 | PHOTOVOLTAIC CELL | ASULAB SA (CH) | 1997-06-04 | — | — | EP | disclosed |
| EP-0606453-A1 | PHOTOVOLTAIC CELL. | ASULAB SA (CH) | 1994-07-20 | — | — | EP | disclosed |
| WO-1994003930-A1 | PHOTOVOLTAIC CELL | ASULAB S.A. (CH) | 1994-02-17 | — | — | WO | disclosed |
| US-5196257-A | BIDIMENSIONAL ORGANIC DIAPHRAGMS AND THEIR PREPARATION PROCESSES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1993-03-23 | — | — | US | disclosed |
| EP-0474533-A1 | Bidimensional organic membranes and process for their preparation | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1992-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210361702-A1 | FLUORO SUBSTITUTED PORPHYRIN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | SLC46A1, CYP2B6, F12 | TERT 843/4885TOP1 287/4885CYP19A1 630/4885 |
| US-11344574-B2 | Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same | SLC46A1, CYP2B6, F12 | TERT 843/4885TOP1 287/4885CYP19A1 630/4885 |
| US-12546743-B2 | Electrochemical sensor and related methods | EPX, MUC1, EPCAM | TERT 3462/4885TOP1 4862/4885CYP19A1 3785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.